← Open Payments lookup

BRANDON MCLAUGHLIN: Open Payments

NPI 1104935071 · CENTRAL CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$574 in 38 payments from 17 companies in 2025. Trend: 2023 $277 · 2024 $347 · 2025 $574

Food & beverage: $574
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$165
E.R. Squibb & Sons, L.L.C.3$48
Otsuka America Pharmaceutical, Inc.2$38
Lundbeck LLC2$34
Amgen Inc.2$32
ABBVIE INC.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$30
Novo Nordisk Inc2$30
Neurocrine BioSciences, Inc.2$29
Ardelyx, Inc.1$26

Products named: UZEDY, REXULTI, AUSTEDO XR, EVENITY, VRAYLAR, ELIQUIS, CAPLYTA, Rybelsus.

Industry payments across NE — which companies pay providers there.